COVID-19Regulatory

Covid-19 antibody tests can help people rejoin society, but some are stuck in China

April 17, 2020 / By Curt DevineDrew GriffinNelli Black and Scott Bronstein, CNN

(CNN) – The first tests for Covid-19 antibodies authorized by US regulators are stuck in China, according to the company behind them.

A spokesperson for the North Carolina-based company Cellex, the maker of a test that can detect whether a person’s blood has virus antibodies, told CNN Chinese regulatory hurdles blocked its production site in China from exporting to the US.

Asked about the timing of the availability of the tests, which received emergency-use authorization from the Food and Drug Administration earlier this month, the Cellex spokesperson said the company should be able to meet demand “shortly” but added, “it may take a little longer than we would like to sort out the supply chain, mass production, shipping and getting through the red tapes.”

The US ambassador to China, Terry Branstad, has said the US embassy is aware of issues regarding medical exports from China and is working with Chinese authorities to address them.

READ THE REST HERE

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button